Theriva Biologics announces positive results from VIRAGE phase 2b trial of VCN─01 plus SoC chemotherapy gemcitabine/nab─...
Theriva Biologics (Theriva), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, announced positive topline outcomes from the VIRAGE phase 2b clinical trial evaluating the …